CTRI/2018/03/012336
Not yet recruiting
未知
Observational and Cross-Sectional Cohort Study of the Natural History and Phenotypic Spectrum of Farber Disease
ConditionsHealth Condition 1: null- Farber Disease
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: null- Farber Disease
- Sponsor
- Enzyvant Farber GmbH
- Status
- Not yet recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •INCL 1\. Living or deceased subjects with diagnosis of Farber disease, based on clinical (diagnosis by a physician based on typical clinical symptoms) and biochemical and/or genetic criteria, as follows:
- •c. Biochemical: An acid ceramidase activity value in white blood cells, cultured skin fibroblasts or other biological sources (e.g., plasma) that is less than 30% of control (normal) values established by the testing laboratory. For deceased subjects only, storage of ceramide in cells from histopathologic sections is also adequate to confirm the diagnosis.
- •a. Genetic: Nucleotide changes within both alleles of the acid ceramidase gene (ASAH1\) or cDNA that indicate, through bioinformatics, gene expression studies, or other methods, a possible loss of function of the acid ceramidase protein.
- •INCL 2\. Informed consent or assent, for living subjects. For deceased subjects it is the responsibility of the PI to ensure that the proper requirements are met according to local laws and regulations.
Exclusion Criteria
- •Potential subjects fulfilling the following criterion are not eligible for participation in the study.
- •EXCL 1\. Current use or history of use in past 30 days of an investigational agent (does not include off\-label use of medications).
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Cross-sectional and retrospective cohort study to investigate serum N-terminal pro-brain natriuretic peptide level in elderly peopleCardiovascular disease HypertensionJPRN-UMIN000036041Hiroshima Atomic Bomb Casualty Council9,300
Active, not recruiting
Not Applicable
The impact of rotavirus vaccine introduction in SAsevere gastroenteritisInfection - Other infectious diseasesACTRN12611000559910Children, Youth and Women's health Service200
Completed
Not Applicable
An observational cross sectional cohort study to estimate the frequency of hepatitis E virus (HEV) infection in neurological disease of inflammatory/ immune mediated origin and ischemic strokepost infectious nervous system diseasespost-infectious neurological diseases1004743810034606NL-OMON42390Jeroen Bosch Ziekenhuis100
Completed
Not Applicable
Cross-sectional and cohort study investigating the diagnostic and prognositic function of Kampo (Japanese traditional medicine) findingspeople aged 65 or overJPRN-UMIN000003525Oriental Medicine Research Center, Kitasato University567
Completed
Not Applicable
Antioxidants in the risk of cardiovascular diseaseISRCTN12745004Regional Hospital of Pardubice (Czech Republic)140